[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100519586":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":30,"locations":18,"responsibleParty":36,"collaborators":18,"id":38,"slug":39,"hasResults":40,"nctId":41,"briefTitle":42,"officialTitle":42,"acronym":18,"eligibilityCriteria":43,"healthyVolunteers":44,"sex":45,"minAge":46,"maxAge":47,"enrollmentInfo":48,"targetDuration":18,"studyType":51,"phases":52,"briefSummary":54,"conditions":55,"keywords":57,"overallStatus":62,"whyStopped":18,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":18},{"fullName":5,"class":6},"Medical Corps, Israel Defense Force","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Single Dose of 200mg doxycycline","EXPERIMENTAL","Treatment of a single dose of 200mg doxycycline",[13],"Drug: administration of single dose of doxycycline",{"label":15,"type":16,"description":17,"interventionNames":18},"Standard treatment of 5 days doxycycline (200mg at 1st day followed by 4 days of 100mg)","NO_INTERVENTION","Treatment of 5 days doxycycline (200mg at 1st day followed by 4 days of 100mg)",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":18},"DRUG","administration of single dose of doxycycline","Postexposure prophylaxis with Single Dose doxycycline",[9],[26],{"name":27,"affiliation":28,"role":29},"Barak Gordon, MD","Israel defense forces medical corps","STUDY_DIRECTOR",[31],{"name":32,"role":33,"phone":34,"phoneExt":18,"email":35},"Mor Rittblat, MD","CONTACT","0528782526","Rittblat@gmail.com",{"type":37,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR","100519586","postexposure-prophylaxis-with-single-dose-doxycycline-for-the-prevention-of-tick-borne-relapsing-fever-100519586",false,"NCT06045481","Postexposure Prophylaxis With Single Dose Doxycycline for the Prevention of Tick-borne Relapsing Fever","Inclusion Criteria:\n\nIsrael Air Force flight course cadets.\n\nExclusion Criteria:\n\n* Known sensitivity or allergy to doxycycline\n* Fever in the three weeks preceding the performance of the field series\n* Suspicion of the Tick borne disease with recurrent fever three weeks before performing the\n* Incompletion of the field series",true,"ALL","18 Years","30 Years",{"count":49,"type":50},526,"ESTIMATED","INTERVENTIONAL",[53],"NA","The goal of this clinical trial is to compare standard treatment (5 days of doxycycline) vs single dose doxycycline for the prevention of tick-borne relapsing fever in soldiers who found bite marks on their bodies after an activity that includes contact with the ground or staying at a site suspected of being infected with ticks. The main question\\[s\\] it aims to answer are:\n\n* Testing whether preventive treatment with a single dose of doxylin at a dose of 200 mg is effective in preventing recurrent fever, and if so, at what rate\n* Checking the profile and rate of side effects in each one of the proposed treatment protocols Participants will be treated with standard treatment (5 days of doxycycline) or single dose doxycycline.",[56],"Relapsing Fever, Tick-Borne",[58,59,60,61],"Tick-borne Diseases","doxycycline","soldiers","israel defense forces medical corps","NOT_YET_RECRUITING","2024-03-12",{"date":65,"type":66},"2024-03-13","ACTUAL",{"date":68,"type":50},"2024-08-01",{"date":70,"type":50},"2027-10-31",{"name":5,"class":6}]